Cytosorbents Crp
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $9,150 | $8,612 | $9,894 | $9,786 |
Gross Profit | 9,398 | 4,504 | 6,502 | 6,570 |
EBITDA | -8,524 | -3,949 | -2,833 | -4,528 |
EBIT | -8,950 | -4,378 | -3,279 | -4,971 |
Net Income | -7,883 | -2,334 | -4,143 | -6,357 |
Net Change In Cash | 9,150 | 8,612 | 9,894 | 9,786 |
Free Cash Flow | -2,466 | -2,759 | -4,914 | -4,956 |
Cash | 3,279 | 5,685 | 8,458 | 8,608 |
Basic Shares | 54,714 | 54,453 | 54,306 | 54,262 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $25,125 | $36,349 | $29,360 | $40,109 |
Gross Profit | 25,125 | 22,392 | 15,404 | 29,061 |
EBITDA | -19,266 | -29,182 | -30,003 | -22,013 |
EBIT | -21,010 | -31,209 | -31,134 | -23,142 |
Net Income | -20,718 | -28,507 | -32,813 | -24,559 |
Net Change In Cash | 25,125 | 36,349 | 29,360 | 40,109 |
Cost of Revenue | -29,730 | -17,596 | ||
Free Cash Flow | -14,712 | -22,591 | -34,689 | -18,286 |
Cash | 3,279 | 14,131 | 22,145 | 52,138 |
Basic Shares | 54,434 | 44,656 | 43,573 | 43,359 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | -$0.14 |
2024-12-31 | -$0.14 |
2024-09-30 | -$0.04 |
2024-06-30 | -$0.08 |
